Skip to main content
Premium Trial:

Request an Annual Quote

Catch by Gene, C&S Ink Supply Agreement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Catch by Gene (CBYG) today announced a reagent supply agreement with C&S.

The deal, which is initially for $300,000, covers CBYG's test kit products for the identification of sexually transmitted diseases, including the early-stage identification of human papillomavirus. CBYG will initially provide C&S with 60,000 reagents a year, and said in a statement that it anticipates that amount to increase each year "with increased demand requirements in addition to other international distributors."

The Korean company develops, manufactures, and markets in vitro nucleic acid assays. Its technology uses multi-probes based on microplate chemiluminescence or colorimetry for the direct detection of infectious pathogens, such as hepatitis B, HPV, and Chlamydia trachomatis, the company said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.